Collectively, PKM2 expression was significantly correlated with the expression of marker genes from tumor-infiltrating CD8+ T cells, T cells (general), B cells, Neutrophils, DCs, Th1, Th2, Th17, Tfh, Treg, and depleted T cells both in LUAD and LUSC. The gene discussed is CD8A; the disease is neoplasm.